2026 Global: Bowel Management Systems Market-Competitive Review (2032) report
Description
The 2026 Global: Bowel Management Systems Market-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for bowel management systems market by geography and historical trend. The scope of the report extends to sizing of the bowel management systems market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Coloplast A/S, ConvaTec Group plc, Medtronic plc, B. Braun Melsungen AG, and Hollister Incorporated are among the ten major companies shaping the bowel management systems market through complementary portfolios spanning transanal irrigation, fecal management devices, neuromodulation, and clinical support services. Coloplast is recognized for its Peristeen transanal irrigation system and patient‑centred product development and distribution that emphasize home use and clinician training. ConvaTec leverages its Flexi‑Seal fecal management system and broad chronic‑care footprint to focus on infection control and long‑term care adoption. Medtronic’s strengths lie in neuromodulation platforms and transanal irrigation solutions, supported by an extensive installed base and ongoing device upgrades targeting neurogenic bowel dysfunction. B. Braun offers clinical‑grade irrigation and stool management technologies widely used in hospitals, while Hollister concentrates on user comfort, skin protection, and ostomy‑adjacent bowel care products.
Becton, Dickinson and Company (BD), 3M Company, Wellspect HealthCare (Dentsply Sirona), Consure Medical, and Boston Scientific (including Axonics’ portfolio after consolidation) complete the set of leading providers that drive innovation across disposable systems, sensor integration, and connected care. BD and 3M supply disposable components and infection‑control‑oriented consumables that address hygiene and HAI concerns in acute and long‑term care settings. Wellspect brings transanal irrigation expertise and device training programs that improve adherence and clinical outcomes in neurogenic and chronic bowel dysfunction. Consure Medical focuses on cost‑effective solutions for resource‑constrained markets and expanding access in Asia and emerging regions. Boston Scientific’s strategic entry into sacral neuromodulation through the Axonics acquisition strengthens capabilities in implantable therapies and integrated software ecosystems for fecal incontinence management. Collectively these companies invest in R&D, acquisitions, and clinician engagement to develop smaller, MRI‑compatible neuromodulation implants, single‑use disposables, and digital monitoring platforms that enable remote follow‑up and real‑world evidence generation.
Market positioning among these ten leaders reflects complementary competitive advantages—established irrigation and stool management products (Coloplast, Wellspect, ConvaTec), neuromodulation and implantable therapies (Medtronic, Boston Scientific/Axonics), hospital‑grade clinical systems and consumables (B. Braun, BD, 3M), and regionally focused cost‑effective or niche solutions (Hollister, Consure) —which together address acute, chronic, and home‑care segments while responding to rising prevalence of neurogenic bowel dysfunction, aging populations, and infection‑control priorities. Industry trends reported across market analyses emphasize consolidation, product miniaturization, single‑use hygiene solutions, and the emergence of sensor‑enabled and cloud‑connected bowel management devices that aim to reduce complications, cut readmissions, and extend care into home settings.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for bowel management systems market by geography and historical trend. The scope of the report extends to sizing of the bowel management systems market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Coloplast A/S, ConvaTec Group plc, Medtronic plc, B. Braun Melsungen AG, and Hollister Incorporated are among the ten major companies shaping the bowel management systems market through complementary portfolios spanning transanal irrigation, fecal management devices, neuromodulation, and clinical support services. Coloplast is recognized for its Peristeen transanal irrigation system and patient‑centred product development and distribution that emphasize home use and clinician training. ConvaTec leverages its Flexi‑Seal fecal management system and broad chronic‑care footprint to focus on infection control and long‑term care adoption. Medtronic’s strengths lie in neuromodulation platforms and transanal irrigation solutions, supported by an extensive installed base and ongoing device upgrades targeting neurogenic bowel dysfunction. B. Braun offers clinical‑grade irrigation and stool management technologies widely used in hospitals, while Hollister concentrates on user comfort, skin protection, and ostomy‑adjacent bowel care products.
Becton, Dickinson and Company (BD), 3M Company, Wellspect HealthCare (Dentsply Sirona), Consure Medical, and Boston Scientific (including Axonics’ portfolio after consolidation) complete the set of leading providers that drive innovation across disposable systems, sensor integration, and connected care. BD and 3M supply disposable components and infection‑control‑oriented consumables that address hygiene and HAI concerns in acute and long‑term care settings. Wellspect brings transanal irrigation expertise and device training programs that improve adherence and clinical outcomes in neurogenic and chronic bowel dysfunction. Consure Medical focuses on cost‑effective solutions for resource‑constrained markets and expanding access in Asia and emerging regions. Boston Scientific’s strategic entry into sacral neuromodulation through the Axonics acquisition strengthens capabilities in implantable therapies and integrated software ecosystems for fecal incontinence management. Collectively these companies invest in R&D, acquisitions, and clinician engagement to develop smaller, MRI‑compatible neuromodulation implants, single‑use disposables, and digital monitoring platforms that enable remote follow‑up and real‑world evidence generation.
Market positioning among these ten leaders reflects complementary competitive advantages—established irrigation and stool management products (Coloplast, Wellspect, ConvaTec), neuromodulation and implantable therapies (Medtronic, Boston Scientific/Axonics), hospital‑grade clinical systems and consumables (B. Braun, BD, 3M), and regionally focused cost‑effective or niche solutions (Hollister, Consure) —which together address acute, chronic, and home‑care segments while responding to rising prevalence of neurogenic bowel dysfunction, aging populations, and infection‑control priorities. Industry trends reported across market analyses emphasize consolidation, product miniaturization, single‑use hygiene solutions, and the emergence of sensor‑enabled and cloud‑connected bowel management devices that aim to reduce complications, cut readmissions, and extend care into home settings.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
